Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity

ABSTRACT HIV-1 evades antibody-dependent cellular cytotoxicity (ADCC) responses not only by controlling Env conformation and quantity at the cell surface but also by altering NK cell activation via the downmodulation of several ligands of activating and co-activating NK cell receptors. The signaling lymphocyte activation molecule (SLAM) family of receptors, which includes NTB-A and 2B4, act as co-activating receptors to sustain NK cell activation and cytotoxic responses. These receptors cooperate with CD16 (FcγRIII) and other activating receptors to trigger NK cell effector functions. In that context, Vpu-mediated downregulation of NTB-A on HIV-1-infected CD4 T cells was shown to prevent NK cell degranulation via an homophilic interaction, thus contributing to ADCC evasion. However, less is known on the capacity of HIV-1 to evade 2B4-mediated NK cell activation and ADCC. Here, we show that HIV-1 downregulates the ligand of 2B4, CD48, from the surface of infected cells in a Vpu-dependent manner. This activity is conserved among Vpu proteins from the HIV-1/SIVcpz lineage and depends on conserved residues located in its transmembrane domain and dual phosphoserine motif. We show that NTB-A and 2B4 stimulate CD16-mediated NK cell degranulation and contribute to ADCC responses directed to HIV-1-infected cells to the same extent. Our results suggest that HIV-1 has evolved to downmodulate the ligands of both SLAM receptors to evade ADCC. IMPORTANCE Antibody-dependent cellular cytotoxicity (ADCC) can contribute to the elimination of HIV-1-infected cells and HIV-1 reservoirs. An in-depth understanding of the mechanisms used by HIV-1 to evade ADCC might help develop novel approaches to reduce the viral reservoirs. Members of the signaling lymphocyte activation molecule (SLAM) family of receptors, such as NTB-A and 2B4, play a key role in stimulating NK cell effector functions, including ADCC. Here, we show that Vpu downmodulates CD48, the ligand of 2B4, and this contributes to protect HIV-1-infected cells from ADCC. Our results highlight the importance of the virus to prevent the triggering of the SLAM receptors to evade ADCC. Antibody-dependent cellular cytotoxicity (ADCC) can contribute to the elimination of HIV-1-infected cells and HIV-1 reservoirs. An in-depth understanding of the mechanisms used by HIV-1 to evade ADCC might help develop novel approaches to reduce the viral reservoirs. Members of the signaling lymphocyte activation molecule (SLAM) family of receptors, such as NTB-A and 2B4, play a key role in stimulating NK cell effector functions, including ADCC. Here, we show that Vpu downmodulates CD48, the ligand of 2B4, and this contributes to protect HIV-1-infected cells from ADCC. Our results highlight the importance of the virus to prevent the triggering of the SLAM receptors to evade ADCC.

[1]  Son Thanh Nguyen,et al.  Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4+ T cell reservoir , 2022, bioRxiv.

[2]  B. Haynes,et al.  HIV-1 Vpu restricts Fc-mediated effector functions in vivo , 2022, bioRxiv.

[3]  J. Kappes,et al.  Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4+ T Cell , 2021, bioRxiv.

[4]  J. Sodroski,et al.  Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir. , 2021, Cell host & microbe.

[5]  Genny Del Zotto,et al.  Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy , 2020, Cells.

[6]  D. Kaufmann,et al.  HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells , 2020, Journal of Virology.

[7]  Brennan S. Dirk,et al.  Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses , 2019, mBio.

[8]  Domènec Farré,et al.  Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor , 2019, PLoS pathogens.

[9]  J. Kappes,et al.  Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses , 2018, Journal of Virology.

[10]  D. Kaufmann,et al.  Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses , 2018, mBio.

[11]  D. Kaufmann,et al.  Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals. , 2018, Virology.

[12]  F. Kirchhoff,et al.  Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo. , 2018, Cell host & microbe.

[13]  D. Kaufmann,et al.  Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity , 2017, Journal of Virology.

[14]  Domènec Farré,et al.  Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion , 2017, European journal of immunology.

[15]  J. Sodroski,et al.  Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses , 2017, Journal of Virology.

[16]  S. Kent,et al.  NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity. , 2016, AIDS research and human retroviruses.

[17]  G. Learn,et al.  The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild. , 2016, Cell host & microbe.

[18]  F. Kirchhoff,et al.  Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance , 2016, mBio.

[19]  V. Planelles,et al.  CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells. , 2016, AIDS research and human retroviruses.

[20]  A. Chakraborty,et al.  Enhanced clearance of HIV-1–infected cells by broadly neutralizing antibodies against HIV-1 in vivo , 2016, Science.

[21]  H. Mouquet,et al.  Elimination of HIV-1-infected cells by broadly neutralizing antibodies , 2016, Nature Communications.

[22]  O. Mandelboim,et al.  The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity , 2016, Oncotarget.

[23]  B. Walker,et al.  Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity , 2015, Journal of Virology.

[24]  F. Kirchhoff,et al.  A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies , 2015, Journal of Virology.

[25]  M. Colonna,et al.  DNAM-1 controls NK cell activation via an ITT-like motif , 2015, The Journal of experimental medicine.

[26]  Domènec Farré,et al.  Signaling Lymphocytic Activation Molecule Family Receptor Homologs in New World Monkey Cytomegaloviruses , 2015, Journal of Virology.

[27]  S. Neil,et al.  Serine Phosphorylation of HIV-1 Vpu and Its Binding to Tetherin Regulates Interaction with Clathrin Adaptors , 2015, PLoS pathogens.

[28]  J. Sodroski,et al.  CD4 mimetics sensitize HIV-1-infected cells to ADCC , 2015, Proceedings of the National Academy of Sciences.

[29]  J. Overbaugh,et al.  Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality. , 2015, Cell host & microbe.

[30]  M. Schindler,et al.  HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes , 2015, Journal of Virology.

[31]  J. Richard,et al.  Conformational evaluation of HIV-1 trimeric envelope glycoproteins using a cell-based ELISA assay. , 2014, Journal of visualized experiments : JoVE.

[32]  U. Schubert,et al.  HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain. , 2014, Virology.

[33]  M. Nussenzweig,et al.  Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice , 2014, Cell.

[34]  E. Boritz,et al.  Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression , 2014, Nature.

[35]  S. López-Vergès,et al.  NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells , 2014, Front. Immunol..

[36]  D. Burton,et al.  Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity , 2014, Proceedings of the National Academy of Sciences.

[37]  D. Fierer,et al.  HIV-1 Vpu Antagonism of Tetherin Inhibits Antibody-Dependent Cellular Cytotoxic Responses by Natural Killer Cells , 2014, Journal of Virology.

[38]  Domènec Farré,et al.  Cytomegalovirus m154 Hinders CD48 Cell-Surface Expression and Promotes Viral Escape from Host Natural Killer Cell Control , 2014, PLoS pathogens.

[39]  J. Sodroski,et al.  Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity , 2013, Journal of Virology.

[40]  H. Ding,et al.  Relative resistance of HIV-1 founder viruses to control by interferon-alpha , 2013, Retrovirology.

[41]  É. Cohen,et al.  The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. , 2013 .

[42]  E. Haddad,et al.  Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice , 2013, Retrovirology.

[43]  Frank Kirchhoff,et al.  HIV-1 Vpu affects the anterograde transport and the glycosylation pattern of NTB-A. , 2013, Virology.

[44]  Feng Gao,et al.  Phenotypic properties of transmitted founder HIV-1 , 2013, Proceedings of the National Academy of Sciences.

[45]  Sumati Rajagopalan,et al.  Controlling natural killer cell responses: integration of signals for activation and inhibition. , 2013, Annual review of immunology.

[46]  T. Friedrich,et al.  Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques , 2013, Journal of Virology.

[47]  G. Learn,et al.  Human Tetherin Exerts Strong Selection Pressure on the HIV-1 Group N Vpu Protein , 2012, PLoS pathogens.

[48]  Jerome H. Kim,et al.  Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family , 2012, Journal of Virology.

[49]  A. Trkola,et al.  ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge , 2012, PLoS pathogens.

[50]  J. Overbaugh,et al.  HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads , 2012, PLoS pathogens.

[51]  G. Learn,et al.  Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation. , 2012, The Journal of clinical investigation.

[52]  G. Pietersz,et al.  Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond , 2012, Nature Reviews Drug Discovery.

[53]  Mamoru Ito,et al.  Vpu Augments the Initial Burst Phase of HIV-1 Propagation and Downregulates BST2 and CD4 in Humanized Mice , 2012, Journal of Virology.

[54]  A. Santoni,et al.  The Human Immunodeficiency Virus Type 1 Nef and Vpu Proteins Downregulate the Natural Killer Cell-Activating Ligand PVR , 2012, Journal of Virology.

[55]  H. Ding,et al.  Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages , 2011, Journal of Virology.

[56]  E. Campbell,et al.  Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. , 2010, Cell host & microbe.

[57]  J. Richard,et al.  HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing. , 2010, Blood.

[58]  G. Learn,et al.  Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. , 2009, Cell host & microbe.

[59]  E. Zimmerman,et al.  HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response , 2009, PLoS pathogens.

[60]  A. Moses,et al.  Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a βTrCP-Dependent Mechanism , 2009, Journal of Virology.

[61]  A. Perelson,et al.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection , 2009, The Journal of experimental medicine.

[62]  H. Agut,et al.  HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells , 2009, AIDS.

[63]  R. Benarous,et al.  Vpu Antagonizes BST-2–Mediated Restriction of HIV-1 Release via β-TrCP and Endo-Lysosomal Trafficking , 2009, PLoS pathogens.

[64]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[65]  Lewis L Lanier,et al.  Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.

[66]  Marc C. Johnson,et al.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. , 2008, Cell host & microbe.

[67]  P. Bieniasz,et al.  Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu , 2008, Nature.

[68]  P. Sharp,et al.  Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. , 2007, Virology.

[69]  J. Ward,et al.  HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. , 2007, Blood.

[70]  Z. Weng,et al.  Generation of Infectious Molecular Clones of Simian Immunodeficiency Virus from Fecal Consensus Sequences of Wild Chimpanzees , 2007, Journal of Virology.

[71]  Eric O Long,et al.  Activation, coactivation, and costimulation of resting human natural killer cells , 2006, Immunological reviews.

[72]  C. Watzl,et al.  Molecular Analysis of NTB-A Signaling: A Role for EAT-2 in NTB-A-Mediated Activation of Human NK Cells1 , 2006, The Journal of Immunology.

[73]  C. Watzl,et al.  2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells. , 2006, International immunology.

[74]  David M. Rocke,et al.  Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection , 2005, Journal of Virology.

[75]  Peter D. Kwong,et al.  Antigenic conservation and immunogenicity of the HIV coreceptor binding site , 2005, The Journal of experimental medicine.

[76]  C. Watzl,et al.  Cutting Edge: NTB-A Activates NK Cells via Homophilic Interaction1 , 2004, The Journal of Immunology.

[77]  Eric O Long,et al.  Natural Killer Cell Inhibitory Receptors Block Actin Cytoskeleton-dependent Recruitment of 2B4 (CD244) to Lipid Rafts , 2002, The Journal of experimental medicine.

[78]  J. Clements,et al.  Sustained antibody-dependent cell-mediated cytotoxicity (ADCC) in SIV-infected macaques correlates with delayed progression to AIDS. , 2002, AIDS research and human retroviruses.

[79]  Massimo Morra,et al.  Structural basis for the interaction of the free SH2 domain EAT‐2 with SLAM receptors in hematopoietic cells , 2001, The EMBO journal.

[80]  L. Notarangelo,et al.  NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. , 2001, The Journal of experimental medicine.

[81]  M. Colonna,et al.  Patients with X‐linked lymphoproliferative disease have a defect in 2B4 receptor‐mediated NK cell cytotoxicity , 2000, European journal of immunology.

[82]  Eric O Long,et al.  Cutting Edge: NK Cell Inhibitory Receptors Prevent Tyrosine Phosphorylation of the Activation Receptor 2B4 (CD244)1 , 2000, The Journal of Immunology.

[83]  L. Notarangelo,et al.  X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .

[84]  R. Biassoni,et al.  2B4 functions as a co‐receptor in human NK cell activation , 2000, European journal of immunology.

[85]  R. Haubrich,et al.  Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients. , 1999, The Journal of infectious diseases.

[86]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[87]  S. Tangye,et al.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.

[88]  M. Colonna,et al.  Activating interactions in human NK cell recognition: the role of 2B4‐CD48 , 1999, European journal of immunology.

[89]  W. Greene,et al.  A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor , 1998, Current Biology.

[90]  J. Yewdell,et al.  CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway , 1998, Journal of Virology.

[91]  D. Thomas,et al.  A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.

[92]  J. Margolick,et al.  HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. , 1996, Journal of immunology.

[93]  T. Mcclanahan,et al.  DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. , 1996, Immunity.

[94]  A. Purohit,et al.  A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. , 1993, Journal of immunology.

[95]  M. Amiot,et al.  Expression of the Blast-1 activation/adhesion molecule and its identification as CD48. , 1991, Journal of immunology.

[96]  W. O'brien,et al.  HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain , 1990, Nature.

[97]  Andreas Meyerhans,et al.  Genetic organization of a chimpanzee lentivirus related to HIV-1 , 1990, Nature.

[98]  I Quinti,et al.  Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. , 1990, The Journal of infectious diseases.

[99]  J. Lawrence,et al.  Blast-1 possesses a glycosyl-phosphatidylinositol (GPI) membrane anchor, is related to LFA-3 and OX-45, and maps to chromosome 1q21-23 , 1989, The Journal of experimental medicine.

[100]  A. Santoni,et al.  Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. , 2007, The Journal of general virology.

[101]  Eric O Long,et al.  Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. , 2006, Blood.

[102]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.